NINTEDANIB FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS - INITIAL CLINICAL EXPERIENCE IN A UK COHORT

被引：4
|
作者：
Fletcher, S. V. [1 ]
Jones, M. G. [1 ]
Renzoni, E. [2 ]
Parfrey, H. [3 ]
Hoyles, R. [4 ]
Spinks, K. [5 ]
Kokosi, M.
Kwok, A. [6 ]
Warburton, C. [6 ]
Titmuss, V. [5 ]
Maher, T. [2 ]
Chua, F. [2 ]
Wells, A. [2 ]
Richeldi, L. [1 ]
Spencer, L. G. [6 ]
机构：
[1] Southampton Univ Hosp, Southampton, Hants, England
[2] Royal Brampton Hosp, ILD Unit, London, England
[3] Papworth Hosp, Cambridge CB3 8RE, England
[4] John Radcliffe Hosp, Oxford, England
[5] Queen Alexandra Hosp, Portsmouth, Hants, England
[6] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England
来源：
THORAX | 2015年 / 70卷
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1136/thoraxjnl-2015-207770.146
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P9
引用
收藏
页码：A78 / A78
页数：1
相关论文
共 50 条
  • [41] LONG-TERM NINTEDANIB TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Song, Jin Woo
    Quaresma, Manuel
    Kaye, Mitchell
    Stansen, Wibke
    Stowasser, Susanne
    Kreuter, Michael
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [42] Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
    Nakano, Akiko
    Ohkubo, Hirotsugu
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Takemura, Masaya
    Maeno, Ken
    Ito, Yutaka
    Oguri, Tetsuya
    Niimi, Akio
    INTERNAL MEDICINE, 2019, 58 (08) : 1141 - 1144
  • [43] Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
    Inoue, Daisuke
    Nishi, Hiroshi
    Honda, Kenjiro
    Ishii, Taisuke
    Abe, Hiroyuki
    Sato, Masaaki
    Nangaku, Masaomi
    CLINICAL NEPHROLOGY, 2020, 93 (01) : 47 - 50
  • [44] Effect of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
    Kawada, Tomoyuki
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (09) : 1274 - +
  • [45] Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
    Richeldi, Luca
    du Bois, Roland M.
    Raghu, Ganesh
    Azuma, Arata
    Brown, Kevin K.
    Costabel, Ulrich
    Cottin, Vincent
    Flaherty, Kevin R.
    Hansell, David M.
    Inoue, Yoshikazu
    Kim, Dong Soon
    Kolb, Martin
    Nicholson, Andrew G.
    Noble, Paul W.
    Selman, Moises
    Taniguchi, Hiroyuki
    Brun, Michele
    Le Maulf, Florence
    Girard, Mannaig
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Disse, Bernd
    Collard, Harold R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (22): : 2071 - 2082
  • [46] Evaluation of treatment with Nintedanib in patients with idiopathic pulmonary fibrosis: a proteomical approach
    Landi, Claudia
    Cameli, Paolo
    Bergantini, Laura
    D'Alessandro, Miriana
    Bianchi, Laura
    Shaba, Enxhi
    Rottoli, Paola
    Bini, Luca
    Bargagli, Elena
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [47] Nintedanib slows progression in idiopathic pulmonary fibrosis
    Weiss, Johannes
    PNEUMOLOGIE, 2018, 72 (02): : 101 - 101
  • [48] Nintedanib for idiopathic pulmonary fibrosis: An Asian perspective
    Chambers, Daniel C.
    RESPIROLOGY, 2016, 21 (08) : 1342 - 1343
  • [49] Nintedanib for idiopathic pulmonary fibrosis in the Japanese population
    Jo, Helen E.
    Corte, Tamera J.
    RESPIROLOGY, 2017, 22 (04) : 630 - 631
  • [50] Pirfenidone vs nintedanib for treatment of idiopathic pulmonary fibrosis in clinical practice: efficacy, tolerability, and adverse effects
    Sadon, Amal A. E-A
    Kenawy, Ahmed S.
    Abdelsalam, Ashraf H.
    Attia, Hosam M.
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (03): : 549 - 559
12345